LitAlert ~~ GeneLit.com

    • CanRisk Tool - A web interface for the prediction of breast and ovarian cancer risk and the likelihood of carrying genetic pathogenic variants.
    • Carver T, Hartley S, Lee A, Cunningham AP, Archer S, de Villiers CB, Roberts J, Ruston R, Walter FM, Tischkowitz M, Easton DF, Antoniou AC.
    • Cancer Epidemiol Biomarkers Prev. 2020 Dec 17. doi: 10.1158/1055-9965.EPI-20-1319. Epub ahead of print.
    • Whole-exome sequencing of non-BRCA1/BRCA2 mutation carrier cases at high-risk for hereditary breast/ovarian cancer.
    • Felicio PS, Grasel RS, Campacci N, de Paula AE, Galvão HCR, Torrezan GT, Sabato CS, Fernandes GC, Souza CP, Michelli RD, Andrade CE, Barros BDF, Matsushita MM, Revil T, Ragoussis J, Couch FJ, Hart SN, Reis RM, Melendez ME, Tonin PN, Carraro DM, Palmero EI.
    • Hum Mutat. 2020 Dec 16. doi: 10.1002/humu.24158. Epub ahead of print.
    • Psychosocial outcomes following germline multigene panel testing in an ethnically and economically diverse cohort of patients.
    • Culver JO, Ricker CN, Bonner J, Kidd J, Sturgeon D, Hodan R, Kingham K, Lowstuter K, Chun NM, Lebensohn AP, Rowe-Teeter C, Levonian P, Partynski K, Lara-Otero K, Hong C, Morales Pichardo J, Mills MA, Brown K, Lerman C, Ladabaum U, McDonnell KJ, Ford JM, Gruber SB, Kurian AW, Idos GE.
    • Cancer. 2020 Dec 15. doi: 10.1002/cncr.33357. Epub ahead of print.
    • CHEK2 Germline Variants in Cancer Predisposition: Stalemate Rather than Checkmate.
    • Stolarova L, Kleiblova P, Janatova M, Soukupova J, Zemankova P, Macurek L, Kleibl Z.
    • Cells. 2020 Dec 12;9(12):E2675. doi: 10.3390/cells9122675.
    • Hereditary Diffuse Gastric Cancer: A Comparative Cohort Study According to Pathogenic Variant Status.
    • Marwitz T, Hüneburg R, Spier I, Lau JF, Kristiansen G, Lingohr P, Kalff JC, Aretz S, Nattermann J, Strassburg CP.
    • Cancers (Basel). 2020 Dec 11;12(12):E3726. doi: 10.3390/cancers12123726.